Van den Bosch F - Search Results

1

Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT).

Burmester GR, Van den Bosch F, Tesser J, Shmagel A, Liu Y, Khan N, Camp HS, Kivitz A. Burmester GR, et al. Among authors: van den bosch f. J Rheumatol. 2024 Jul 1;51(7):663-672. doi: 10.3899/jrheum.2023-1062. J Rheumatol. 2024. PMID: 38621793 Free article. Clinical Trial.

2

Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis.

Elewaut D, De Keyser F, Van Den Bosch F, Lazarovits AI, De Vos M, Cuvelier C, Verbruggen G, Mielants H, Veys EM. Elewaut D, et al. Among authors: van den bosch f. J Rheumatol. 1998 Oct;25(10):1932-7. J Rheumatol. 1998. PMID: 9779846

3

Broadening of the T cell receptor spectrum among rheumatoid arthritis synovial cell-lines in relation to disease duration.

Elewaut D, De Keyser F, Van den Bosch F, Verbruggen G, Veys EM. Elewaut D, et al. Among authors: van den bosch f. Clin Exp Rheumatol. 2000 Mar-Apr;18(2):201-7. Clin Exp Rheumatol. 2000. PMID: 10812492

4

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.

Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP, Dawes PT, Gömör B, Van Den Bosch F, Nordström D, Bjorneboe O, Dahl R, Horslev-Petersen K, Rodriguez De La Serna A, Molloy M, Tikly M, Oed C, Rosenburg R, Loew-Friedrich I. Emery P, et al. Among authors: van den bosch f. Rheumatology (Oxford). 2000 Jun;39(6):655-65. doi: 10.1093/rheumatology/39.6.655. Rheumatology (Oxford). 2000. PMID: 10888712 Clinical Trial.

5

Decrease of disease activity under ineffective therapy in DMARD-naive patients with early rheumatoid arthritis: role of antibody profiles and carriage of the HLA shared epitope in predicting decrease of disease activity.

Vander Cruyssen B, Miltenburg AM, Van den Bosch F, Houbiers JG, Wittoek R, Boots AM, De Keyser F. Vander Cruyssen B, et al. Among authors: van den bosch f. J Rheumatol. 2007 Oct;34(10):1992-6. J Rheumatol. 2007. PMID: 17924607

6

Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab.

Braun J, van der Heijde D, Doyle MK, Han C, Deodhar A, Inman R, de Vlam K, Burmester GR, Van den Bosch F, Xu S, Visvanathan S, Rahman MU. Braun J, et al. Among authors: van der heijde d, van den bosch f. Arthritis Rheum. 2009 Aug 15;61(8):1032-6. doi: 10.1002/art.24865. Arthritis Rheum. 2009. PMID: 19644896 Free article. Clinical Trial.

7

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.

Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM; IMAGE Investigators. Tak PP, et al. Ann Rheum Dis. 2011 Jan;70(1):39-46. doi: 10.1136/ard.2010.137703. Epub 2010 Oct 11. Ann Rheum Dis. 2011. PMID: 20937671 Clinical Trial.

8

The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab.

Heldmann F, Brandt J, van der Horst-Bruinsma IE, Landewe R, Sieper J, Burmester GR, van den Bosch F, de Vlam K, Geusens P, Gaston H, Schewe S, Appelboom T, Emery P, Dougados M, Leirisalo-Repo M, Breban M, Listing J, Braun J. Heldmann F, et al. Among authors: van der horst bruinsma ie, van den bosch f. Clin Exp Rheumatol. 2011 Jul-Aug;29(4):672-80. Epub 2011 Aug 31. Clin Exp Rheumatol. 2011. PMID: 21906431 Clinical Trial.

9

Tofacitinib versus methotrexate in rheumatoid arthritis.

Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV, Zang C, Zwillich SH, van Vollenhoven RF; ORAL Start Investigators. Lee EB, et al. N Engl J Med. 2014 Jun 19;370(25):2377-86. doi: 10.1056/NEJMoa1310476. N Engl J Med. 2014. PMID: 24941177 Free article. Clinical Trial.

10

Clinical remission in patients with active psoriatic arthritis treated with adalimumab and correlations in joint and skin manifestations.

Van den Bosch F, Kavanaugh A, Kron M, Kupper H, Mease PJ. Van den Bosch F, et al. J Rheumatol. 2015 Jun;42(6):952-9. doi: 10.3899/jrheum.140312. Epub 2015 Apr 1. J Rheumatol. 2015. PMID: 25834212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

366 results

Search Page

Filters